MINNEAPOLIS - Nov. 16, 2017 - Cell Culture Company (C3) announced today the promotion of Teresa Markoe to Vice President of Finance and Human Resources. Ms. Markoe will oversee all accounting, financial reporting and human resources operations. Read More...

MINNEAPOLIS - Nov. 16, 2017 - Cell Culture Company (C3) announced today the promotion of Rebecca Thompson, Ph.D. to Vice President of Quality. Dr. Thompson will oversee all contract manufacturing, lab operations and quality management systems for C3. Read More...

MINNEAPOLIS - Nov. 16, 2017 - Cell Culture Company (C3) announced today the promotion of Erin Rasch to Vice President of Sales & Marketing. Ms. Rasch will oversee all sales, marketing and corporate development activities for C3. Read More...

MINNEAPOLIS - (Business Wire) - Nov. 10, 2016 - Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, announced today it has entered into an agreement with a China-based joint venture to produce a clinical-grade antibody-based therapeutic vaccine targeting pancreatic cancer. Read More...

MINNEAPOLIS – Jan. 20, 2016 – Biovest International Inc. announced that it will spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named "Cell Culture Company, LLC." Cell Culture Company will supply automated single-use perfusion bioreactor systems and custom mammalian cell and protein manufacturing services to the diagnostic, therapeutic, and animal healthcare industries. Read More...